Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 209


Redundancy of the influenza A virus-specific cytotoxic T lymphocyte response in HLA-B*2705 transgenic mice limits the impact of a mutation in the immunodominant NP(383-391) epitope on influenza pathogenesis.

Bodewes R, Geelhoed-Mieras MM, Nieuwkoop NJ, Hanson JA, David CS, Fouchier RA, Osterhaus AD, Rimmelzwaan GF.

Virus Res. 2011 Jan;155(1):123-30. doi: 10.1016/j.virusres.2010.09.008. Epub 2010 Sep 21.


A mutation in the HLA-B*2705-restricted NP383-391 epitope affects the human influenza A virus-specific cytotoxic T-lymphocyte response in vitro.

Berkhoff EG, Boon AC, Nieuwkoop NJ, Fouchier RA, Sintnicolaas K, Osterhaus AD, Rimmelzwaan GF.

J Virol. 2004 May;78(10):5216-22.


Influenza virus CTL epitopes, remarkably conserved and remarkably variable.

Rimmelzwaan GF, Kreijtz JH, Bodewes R, Fouchier RA, Osterhaus AD.

Vaccine. 2009 Oct 23;27(45):6363-5. doi: 10.1016/j.vaccine.2009.01.016.


Sequence variation in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes.

Rimmelzwaan GF, Boon AC, Voeten JT, Berkhoff EG, Fouchier RA, Osterhaus AD.

Virus Res. 2004 Jul;103(1-2):97-100.


CTL recognition of a protective immunodominant influenza A virus nucleoprotein epitope utilizes a highly restricted Vbeta but diverse Valpha repertoire: functional and structural implications.

Zhong W, Dixit SB, Mallis RJ, Arthanari H, Lugovskoy AA, Beveridge DL, Wagner G, Reinherz EL.

J Mol Biol. 2007 Sep 14;372(2):535-48. Epub 2007 Jun 27.


T-cell tolerance for variability in an HLA class I-presented influenza A virus epitope.

Wahl A, McCoy W, Schafer F, Bardet W, Buchli R, Fremont DH, Hildebrand WH.

J Virol. 2009 Sep;83(18):9206-14. doi: 10.1128/JVI.00932-09. Epub 2009 Jun 24.


Assessment of the extent of variation in influenza A virus cytotoxic T-lymphocyte epitopes by using virus-specific CD8+ T-cell clones.

Berkhoff EG, Geelhoed-Mieras MM, Fouchier RA, Osterhaus AD, Rimmelzwaan GF.

J Gen Virol. 2007 Feb;88(Pt 2):530-5.


Antigen-specific CD8(+) T cells persist in the upper respiratory tract following influenza virus infection.

Wiley JA, Hogan RJ, Woodland DL, Harmsen AG.

J Immunol. 2001 Sep 15;167(6):3293-9.


Co-expression of HLA-B7 and HLA-B27 alleles is associated with B7-restricted immunodominant responses following influenza infection.

Akram A, Inman RD.

Eur J Immunol. 2013 Dec;43(12):3254-67. doi: 10.1002/eji.201343597. Epub 2013 Oct 20.


Functional constraints of influenza A virus epitopes limit escape from cytotoxic T lymphocytes.

Berkhoff EG, de Wit E, Geelhoed-Mieras MM, Boon AC, Symons J, Fouchier RA, Osterhaus AD, Rimmelzwaan GF.

J Virol. 2005 Sep;79(17):11239-46.


The loss of immunodominant epitopes affects interferon-gamma production and lytic activity of the human influenza virus-specific cytotoxic T lymphocyte response in vitro.

Berkhoff EG, Geelhoed-Mieras MM, Verschuren EJ, van Baalen CA, Gruters RA, Fouchier RA, Osterhaus AD, Rimmelzwaan GF.

Clin Exp Immunol. 2007 May;148(2):296-306. Epub 2007 Feb 26.


Significant impact of sequence variations in the nucleoprotein on CD8 T cell-mediated cross-protection against influenza A virus infections.

Zhong W, Liu F, Dong L, Lu X, Hancock K, Reinherz EL, Katz JM, Sambhara S.

PLoS One. 2010 May 11;5(5):e10583. doi: 10.1371/journal.pone.0010583.


Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes.

Voeten JT, Bestebroer TM, Nieuwkoop NJ, Fouchier RA, Osterhaus AD, Rimmelzwaan GF.

J Virol. 2000 Aug;74(15):6800-7.


Emergence of new influenza A viruses which carry an escape mutation of the HLA-B27-restricted CTL epitope of NP in Japan.

Kashiwagi T, Hamada N, Iwahashi J, Hara K, Ueda T, Noguchi H, Toyoda T.

Microbiol Immunol. 2000;44(10):867-70.


Infection of mice with a human influenza A/H3N2 virus induces protective immunity against lethal infection with influenza A/H5N1 virus.

Kreijtz JH, Bodewes R, van den Brand JM, de Mutsert G, Baas C, van Amerongen G, Fouchier RA, Osterhaus AD, Rimmelzwaan GF.

Vaccine. 2009 Aug 6;27(36):4983-9. doi: 10.1016/j.vaccine.2009.05.079. Epub 2009 Jun 16.

Items per page

Supplemental Content

Write to the Help Desk